RESEARCH TRIANGLE PARK, NC--(Marketwire - October 21, 2008) - According to the recently
published report, "Investigator-Initiated Trials: Building Superior IIT
Capabilities," developed by pharmaceutical market research leader Cutting
Edge Information, first-look screening activities eliminate 11% of all IIT
proposals a company receives (
www.investigatorinitiatedtrials.com). Even
this small minority, though, saves both time and money during later
secondary screenings by the formal committee.
The most effective IIT departments have stringent review policies. Many
companies compare proposals to a pre-set list -- not only must every "t" be
crossed and every "i" dotted, but proposals must match with corporate goals
before progressing to the formal committee. Though this process arguably
causes potential loss of advantageous proposals, the companies have
determined that the cost of investigating said proposals and the expenses
necessary to align the company with the proposals outweigh the benefits.
"In these instances," says Eric Bolesh, lead author of the report, "it is
more cost-effective to the company for the proposals to enable a competitor
to prosper than to incur all the expenses necessary to see the projects to
completion. With the competition acting in like manner, it all balances
out in the end."
Some companies take the review process a step further. On average, the
initial review process takes 27.8 days to complete. These companies have
found a way to shorten this first pass: Instead of accepting full-length
proposals from every investigator, they only accept shorter abstracts that
take less time to review. Of course, should any prove interesting, the
companies promptly request the standard full proposals from those
investigators.
To offer a comprehensive look at the current state of IIT management,
"Investigator-Initiated Trials: Building Superior IIT Capabilities"
provides data benchmarks that will enable companies to improve their IIT
initiatives. Surveyed respondents reveal difficulties in selecting viable
study opportunities, tracking studies, overseeing clinical trial management
and making use of study findings. Findings center on the following topics:
-- Companies' assessments of IIT performance and areas of improvement
-- Study proposal review and evaluation timelines
-- Budgets and funding
-- IIT program profiles
Download a free summary of "Investigator-Initiated Trials: Building
Superior IIT Capabilities" or purchase the report at:
http://www.cuttingedgeinfo.com/investigatorinitiatedtrials/PH114_Download.asp#body.
Contact Information: For questions about the report, please contact
Eric Bolesh
919-433-0209